A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)


August 1, 2011

Clinical trial

Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.

Brown DM, Campochiaro PA, Bhisitkul RB, Ho AC, Gray S, Saroj N, Adamis AP, Rubio RG, Murahashi WY.

Ophthalmology. 2011 Aug;118(8):1594-602.
Full text | Metrics.

June 1, 2010

Clinical trial

Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.

Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG.

Ophthalmology. 2010 Jun;117(6):1102-1112.e1.
Full text | Metrics.

Share This Article :

Updated on March 7th, 2022

Source Archive